Forsidebilde av showet GLP-1 Drugs and Sleep Apnea — A Breakthrough?

GLP-1 Drugs and Sleep Apnea — A Breakthrough?

Podkast av Inception Point AI

engelsk

Teknologi og vitenskap

Prøv gratis i 14 dager

99 kr / Måned etter prøveperioden.Avslutt når som helst.

  • 20 timer lydbøker i måneden
  • Eksklusive podkaster
  • Gratis podkaster
Prøv gratis

Les mer GLP-1 Drugs and Sleep Apnea — A Breakthrough?

Discover how tirzepatide became the first FDA-approved drug for obstructive sleep apnea, offering hope to millions struggling with CPAP machines. Julia Cartwright investigates the science, patient experiences, and clinical implications of this breakthrough treatment that goes far beyond simple weight loss. For more content like this, visit QuietPlease.ai This content was created in partnership and with the help of Artificial Intelligence AI.

Alle episoder

5 Episoder

episode GLP-1 Drugs and Sleep Apnea — Uncover the breakthrough reshaping treatment with Julia Cartwright cover

GLP-1 Drugs and Sleep Apnea — Uncover the breakthrough reshaping treatment with Julia Cartwright

Join Julia Cartwright as she explores the groundbreaking approval of GLP-1 drugs for sleep apnea treatment, a potential game-changer for thirty million Americans frustrated with traditional CPAP therapy. Discover the real science, patient outcomes, and what this breakthrough means for anyone seeking alternatives that actually work. Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTV This content was created in partnership and with the help of Artificial Intelligence AI.

7. april 2026 - 32 s
episode GLP-1 Drugs and Sleep Apnea — A Breakthrough? - 30 Million Americans Tired of Their CPAP cover

GLP-1 Drugs and Sleep Apnea — A Breakthrough? - 30 Million Americans Tired of Their CPAP

Join host Julia Cartwright as she explores tirzepatide's groundbreaking FDA approval for obstructive sleep apnea in adults with obesity. We discuss clinical trials showing remarkable AHI reductions, why CPAP adherence fails millions, the drug's multi-pathway mechanisms, and what this pharmaceutical option means for personalized sleep medicine treatment. Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTV This content was created in partnership and with the help of Artificial Intelligence AI.

7. april 2026 - 24 min
episode GLP-1 Drugs and Sleep Apnea — A Breakthrough? - Why Weight Loss Isn't the Whole Story cover

GLP-1 Drugs and Sleep Apnea — A Breakthrough? - Why Weight Loss Isn't the Whole Story

Host Julia Cartwright explores groundbreaking research on GLP-1 drugs and sleep apnea, revealing how medications like tirzepatide work beyond weight loss through brain receptors, anti-inflammatory effects, and metabolic improvements. Drawing on SURMOUNT-OSA trials and emerging science, she explains why these multi-pathway treatments are revolutionizing our understanding of obstructive sleep apnea as a whole-body condition. Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTV This content was created in partnership and with the help of Artificial Intelligence AI.

7. april 2026 - 24 min
episode GLP-1 Drugs and Sleep Apnea — A Breakthrough? - Why Weight Loss Isn't the Whole Story cover

GLP-1 Drugs and Sleep Apnea — A Breakthrough? - Why Weight Loss Isn't the Whole Story

Host Julia Cartwright explores groundbreaking research on GLP-1 drugs and sleep apnea, revealing how medications like tirzepatide work beyond weight loss through brain receptors, anti-inflammatory effects, and metabolic improvements. Drawing on SURMOUNT-OSA trials and emerging science, she explains why these multi-pathway treatments are revolutionizing our understanding of obstructive sleep apnea as a whole-body condition. Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTV This content was created in partnership and with the help of Artificial Intelligence AI.

7. april 2026 - 24 min
episode GLP-1 Drugs and Sleep Apnea — A Breakthrough? - The Trial That Changed Everything cover

GLP-1 Drugs and Sleep Apnea — A Breakthrough? - The Trial That Changed Everything

Join Julia Cartwright as she explores the groundbreaking FDA approval of tirzepatide (Zepbound) for obstructive sleep apnea—the first medication ever approved for this condition. We dive into the SURMOUNT-OSA trials, examining how this weight-loss drug reduced breathing interruptions and eliminated symptoms in 50% of participants, offering new hope beyond CPAP. Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTV This content was created in partnership and with the help of Artificial Intelligence AI.

7. april 2026 - 23 min
Registrer deg for å lytte
Enkelt å finne frem nye favoritter og lett å navigere seg gjennom innholdet i appen
Enkelt å finne frem nye favoritter og lett å navigere seg gjennom innholdet i appen
Liker at det er både Podcaster (godt utvalg) og lydbøker i samme app, pluss at man kan holde Podcaster og lydbøker atskilt i biblioteket.
Bra app. Oversiktlig og ryddig. MYE bra innhold⭐️⭐️⭐️

Velg abonnementet ditt

Mest populær

Premium

20 timer lydbøker

  • Eksklusive podkaster

  • Ingen annonser i Podimo shows

  • Avslutt når som helst

Prøv gratis i 14 dager
Deretter 99 kr / måned

Prøv gratis

Premium Plus

100 timer lydbøker

  • Eksklusive podkaster

  • Ingen annonser i Podimo shows

  • Avslutt når som helst

Prøv gratis i 14 dager
Deretter 169 kr / måned

Prøv gratis

Bare på Podimo

Populære lydbøker

Ofte stilte spørsmål

Flere spørsmål og svar
Prøv gratis

Prøv gratis i 14 dager. 99 kr / Måned etter prøveperioden. Avslutt når som helst.